Atlas Trials

Phage II Trial of Stathmin as Predictive Biomarker for TPF Induction Chemotherapy in OSCC

Clinical trial NCT03326947 · RECRUITING

Trial details

NCT number
NCT03326947
Sponsor
Shanghai Jiao Tong University School of Medicine
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Neoplasm Neck
Start date
2018-01-01
Primary completion
2026-01-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.